Skip to Main Content
Skip Nav Destination

Development of Hepatocellular Carcinoma after Interferon Therapy in Chronic Hepatitis C: Is It Possible to Reduce the Incidence by Ribanirin and IFN Combination Therapy?

Intervirology (2005) 48 (1): 59–63.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Roger Chou
  • Tracy Dana
  • Rongwei Fu
  • Bernadette Zakher
  • Jesse Wagner
  • Shaun Ramirez
  • Sara Grusing
  • Janice H. Jou
JAMA (2020) 323 (10): 976.
  • Roger Chou
  • Daniel Hartung
  • Basmah Rahman
  • Ngoc Wasson
  • Erika Barth Cottrell
  • Rongwei Fu
Annals of Internal Medicine (2013) 158 (2): 114.
  • Mika Kurokawa
  • Naoki Hiramatsu
  • Tsugiko Oze
  • Kiyoshi Mochizuki
  • Takayuki Yakushijin
  • Nao Kurashige
  • Yuko Inoue
  • Takumi Igura
  • Kazuho Imanaka
  • Akira Yamada
  • Masahide Oshita
  • Hideki Hagiwara
  • Eiji Mita
  • Toshifumi Ito
  • Yoshiaki Inui
  • Taizo Hijioka
  • Harumasa Yoshihara
  • Atsuo Inoue
  • Yasuharu Imai
  • Michio Kato
  • Shinichi Kiso
  • Tatsuya Kanto
  • Tetsuo Takehara
  • Akinori Kasahara
  • Norio Hayashi
Hepatology Research (2009) 39 (5): 432.
  • Hiroaki Okuda
Best Practice & Research Clinical Gastroenterology (2007) 21 (1): 161.
  • Mitsuhiko Moriyama
  • Yasuyuki Arakawa
Expert Opinion on Pharmacotherapy (2006) 7 (9): 1163.
  • C.‐H. Hung
  • C.‐M. Lee
  • S.‐N. Lu
  • J.‐H. Wang
  • T.‐H. Hu
  • H.‐D. Tung
  • C.‐H. Chen
  • W.‐J. Chen
  • C.‐S. Changchien
Journal of Viral Hepatitis (2006) 13 (6): 409.

or Create an Account

Close Modal
Close Modal